Stuttgart, Germany

Angelika Hausser

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 5.2

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2012-2023

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovator Angelika Hausser: Advancements in Cell Culture Technology

Introduction

Angelika Hausser, based in Stuttgart, Germany, is a notable inventor renowned for her contributions to the field of cell culture technology. With a portfolio of four patents, her work primarily focuses on enhancing the secretion of biopharmaceutical products from mammalian cells. Her innovative approach integrates genetic engineering techniques to optimize cell lines for improved performance.

Latest Patents

Hausser's latest patents include significant advancements in mammalian cell technology. One patent addresses the use of RNA interference and gene knockout techniques targeting activating transcription factor 6 beta (ATF6B) and a combination of ceramide synthase 2 (CERS2) and TBC1 domain family member 20 (TBC1D20). This innovation leads to improved secretion of therapeutically relevant proteins from engineered mammalian cells.

Another recent patent involves cell engineering utilizing microRNAs (miRNAs). This invention encompasses RNA sequences, expression vectors, and production host cell lines that exhibit altered levels of small non-coding RNAs. These engineered cell lines show enhanced secretion and growth characteristics as compared to standard controls, paving the way for more efficient production of biopharmaceutical products.

Career Highlights

Throughout her career, Angelika Hausser has made significant strides in the biotechnology sector. She has worked with distinguished companies such as Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharma GmbH & Co. KG. Her experience in these reputable organizations has formed the foundation for her path as an inventor and entrepreneur in the biopharmaceutical industry.

Collaborations

Hausser has collaborated with notable professionals in her field, including Monilola Olayioye and Michaela Strotbek. These partnerships exemplify her commitment to advancing scientific knowledge and developing innovative solutions in cell culture technology.

Conclusion

Angelika Hausser stands out as a pioneer in the realm of cell culture technology, with a strong emphasis on enhancing the secretion capabilities of mammalian cells. Her impactful patents and collaborations demonstrate her dedication to improving biopharmaceutical production methods. Through her work, Hausser contributes significantly to the advancement of biotechnology, showcasing the transformative potential of innovation in medical sciences.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…